drugset / Trial / NCT02299804
A Clinical Trial To Evaluate Efficacy And Safety Of Levophencynonate Hydrochloride In Patient With Vertigo
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A Multicenter, Double-Blind, Placebo Controlled, Phase Ⅱa clinical trial to enroll 120 patients with Vertigo Caused By Posterior Circulation Infarction during 7 days, then to evaluate the efficacy of different dose of Levophencynonate Hydrochloric, and provide the effective dosage for phase IIb clinical study, to study the safety of Levophencynonate Hydrochloric.
Timeline
- Start
- 2014-01
- Primary completion
- 2015-05
- Completion
- 2015-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levophencynonate | Unknown | 1 mg | — |
| Subject | Levophencynonate | Unknown | 1.5 mg | — |
Indications
No indication recorded.